NEUROCRINE BIOSCIENCES INC - Common Stock (NBIX)
CUSIP: 64125C109
Q1 2024 13F Holders as of 31 Mar 2024
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 99,963,154
- Total 13F shares
- 93,218,731
- Share change
- +830,721
- Total reported value
- $12,853,312,563
- Put/Call ratio
- 68%
- Price per share
- $137.92
- Number of holders
- 580
- Value change
- +$116,424,918
- Number of buys
- 305
- Number of sells
- 256
Quarterly Holders Quick Answers
What is CUSIP 64125C109?
CUSIP 64125C109 identifies NBIX - NEUROCRINE BIOSCIENCES INC - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 64125C109:
Top shareholders of NBIX - NEUROCRINE BIOSCIENCES INC - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BlackRock Finance, Inc. |
13F
|
Company |
14%
|
13,647,891
|
$1,798,246,116 | — | 31 Dec 2023 | |
| VANGUARD GROUP INC |
13F
|
Company |
9.7%
|
9,710,328
|
$1,279,432,817 | — | 31 Dec 2023 | |
| STATE STREET CORP |
13F
|
Company |
4.1%
|
4,063,336
|
$535,385,151 | — | 31 Dec 2023 | |
| Bellevue Group AG |
13F
|
Company |
2.4%
|
2,430,500
|
$320,242,680 | — | 31 Dec 2023 | |
| MORGAN STANLEY |
13F
|
Company |
2.3%
|
2,326,294
|
$306,512,662 | — | 31 Dec 2023 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
2%
|
1,988,546
|
$262,011,000 | — | 31 Dec 2023 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
1.7%
|
1,735,543
|
$228,675,257 | — | 31 Dec 2023 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.6%
|
1,623,124
|
$213,548,087 | — | 31 Dec 2023 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
1.6%
|
1,551,367
|
$204,409,229 | — | 31 Dec 2023 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
1.5%
|
1,476,949
|
$194,603,000 | — | 31 Dec 2023 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
1.4%
|
1,391,970
|
$183,405,967 | — | 31 Dec 2023 | |
| DODGE & COX |
13F
|
Company |
1.3%
|
1,259,744
|
$165,983,869 | — | 31 Dec 2023 | |
| DSM CAPITAL PARTNERS LLC |
13F
|
Company |
1.2%
|
1,222,009
|
$161,011,906 | — | 31 Dec 2023 | |
| Pictet Asset Management Holding SA |
13F
|
Company |
1.2%
|
1,213,313
|
$159,866,121 | — | 31 Dec 2023 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
1.2%
|
1,199,542
|
$158,051,653 | — | 31 Dec 2023 | |
| Rock Springs Capital Management LP |
13F
|
Company |
1.2%
|
1,196,000
|
$157,584,960 | — | 31 Dec 2023 | |
| BROWN ADVISORY INC |
13F
|
Company |
1.1%
|
1,113,413
|
$146,703,296 | — | 31 Dec 2023 | |
| ARMISTICE CAPITAL, LLC |
13F
|
Company |
1%
|
1,048,000
|
$138,084,480 | — | 31 Dec 2023 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.98%
|
979,060
|
$129,000,999 | — | 31 Dec 2023 | |
| LOS ANGELES CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.92%
|
918,391
|
$121,007,198 | — | 31 Dec 2023 | |
| DEERFIELD MANAGEMENT COMPANY, L.P. |
13F
|
Company |
0.9%
|
896,719
|
$118,151,695 | — | 31 Dec 2023 | |
| Polar Capital Holdings Plc |
13F
|
Company |
0.84%
|
835,833
|
$110,129,356 | — | 31 Dec 2023 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.81%
|
807,281
|
$106,367,344 | — | 31 Dec 2023 | |
| Vestal Point Capital, LP |
13F
|
Company |
0.8%
|
800,000
|
$105,408,000 | — | 31 Dec 2023 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.78%
|
782,044
|
$103,042,117 | — | 31 Dec 2023 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.77%
|
772,310
|
$101,759,565 | — | 31 Dec 2023 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
0.75%
|
752,865
|
$99,197,492 | — | 31 Dec 2023 | |
| AQR CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.74%
|
738,852
|
$97,170,122 | — | 31 Dec 2023 | |
| EAGLE ASSET MANAGEMENT INC |
13F
|
Company |
0.73%
|
728,353
|
$95,967,791 | — | 31 Dec 2023 | |
| BNP Paribas Asset Management Holding S.A. |
13F
|
Company |
0.72%
|
720,593
|
$94,945,000 | — | 31 Dec 2023 | |
| BRAIDWELL LP |
13F
|
Company |
0.72%
|
715,209
|
$94,235,938 | — | 31 Dec 2023 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.69%
|
691,632
|
$91,129,432 | — | 31 Dec 2023 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.69%
|
688,956
|
$90,776,843 | — | 31 Dec 2023 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.69%
|
686,835
|
$90,497,379 | — | 31 Dec 2023 | |
| Invesco Ltd. |
13F
|
Company |
0.67%
|
673,808
|
$88,780,942 | — | 31 Dec 2023 | |
| Avidity Partners Management LP |
13F
|
Company |
0.66%
|
658,000
|
$86,698,080 | — | 31 Dec 2023 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.62%
|
617,453
|
$81,355,608 | — | 31 Dec 2023 | |
| WESTFIELD CAPITAL MANAGEMENT CO LP |
13F
|
Company |
0.59%
|
594,437
|
$78,323,019 | — | 31 Dec 2023 | |
| FIRST TRUST ADVISORS LP |
13F
|
Company |
0.59%
|
590,725
|
$77,833,890 | — | 31 Dec 2023 | |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM |
13F
|
Company |
0.59%
|
586,950
|
$77,336,532 | — | 31 Dec 2023 | |
| GW&K Investment Management, LLC |
13F
|
Company |
0.54%
|
535,962
|
$70,619,000 | — | 31 Dec 2023 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
0.52%
|
519,279
|
$68,420,201 | — | 31 Dec 2023 | |
| Fiera Capital Corp |
13F
|
Company |
0.52%
|
516,865
|
$68,102,133 | — | 31 Dec 2023 | |
| IEQ CAPITAL, LLC |
13F
|
Company |
0.48%
|
482,826
|
$63,617,153 | — | 31 Dec 2023 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.47%
|
472,979
|
$62,319,711 | — | 31 Dec 2023 | |
| Sarissa Capital Management LP |
13F
|
Company |
0.47%
|
470,000
|
$61,927,200 | — | 31 Dec 2023 | |
| JENNISON ASSOCIATES LLC |
13F
|
Company |
0.45%
|
451,462
|
$59,484,633 | — | 31 Dec 2023 | |
| Legal & General Group Plc |
13F
|
Company |
0.44%
|
441,507
|
$58,172,965 | — | 31 Dec 2023 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.43%
|
425,747
|
$56,096,424 | — | 31 Dec 2023 | |
| PRINCIPAL FINANCIAL GROUP INC |
13F
|
Company |
0.42%
|
418,245
|
$55,107,962 | — | 31 Dec 2023 |
Institutional Holders of NEUROCRINE BIOSCIENCES INC - Common Stock (NBIX) as of Q1 2024
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2024 vs Q4 2023 Across Filers
| Investor | Q4 2023 Shares | Q1 2024 Shares | Share Diff | Share Chg % | Q4 2023 Value $ | Q1 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
An asterisk sign (*) next to the price indicates that the price is likely invalid.